EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Early Molecular Testing for Presumptive Genetic Eye Diseases

Marisol Ibarra-Ramírez iD, Jibran Mohamed-Noriega iD, Joel Arenas-Estala iD, David Asael Rodríguez-Torres, Luis Daniel Campos-Acevedo, Marissa L Fernández-de-Luna iD

Genes · 2026

DOI: 10.3390/genes17091092 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Genes, 2026. Verfasst von Marisol Ibarra-Ramírez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, University Hospital and Faculty of Medicine, Autonomous University of Nuevo León (UANL), Monterrey 64460, Mexico. Hauptthemen laut MEDLINE: Genetic Testing, Eye Diseases, Hereditary, Eye Diseases. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genetic eye diseases (GEDs) comprise a heterogeneous group of hereditary and de novo disorders that involve all ocular structures, including the retina, optic nerve, vitreous, anterior segment, and ocular development. Their marked clinical and genetic heterogeneity frequently delays diagnosis and access to genetic counseling, multidisciplinary management, and emerging gene-based therapies. Although ophthalmic deep phenotyping remains essential, we propose an approach that prioritizes genetic analysis, particularly in under-resourced healthcare settings with limited access to advanced imaging and electrophysiological tests.

Methods

We conducted a retrospective observational study of 101 consecutive patients with suspected genetic eye diseases. All were evaluated at a tertiary referral center in northeastern Mexico between January 2020 and August 2023 through comprehensive ophthalmologic examination supplemented by optical coherence tomography, visual-field testing, and fundus photography when clinically indicated. All patients were offered early molecular testing while awaiting future tests, such as electrophysiological testing or further referral visits. Molecular testing consisted of an ophthalmology-focused next-generation sequencing multigene panel.

Results

The primary outcome was molecular diagnostic yield. A clinically actionable molecular diagnosis was established in 45 patients, corresponding to an overall molecular diagnostic yield of 44.6%. A total of 165 variants were identified, including 70 pathogenic, 16 likely pathogenic, 43 variants of uncertain significance, and 36 likely benign variants. Usher syndrome was the most frequent molecular diagnosis (10/45, 22.2%), comprising nine patients with USH2A-associated Usher syndrome type 2 and one patient with MYO7A-associated Usher syndrome type 1B, followed by Stickler syndrome (8/45, 17.8%), oculocutaneous albinism (3/45, 6.7%), and Alström syndrome (2/45, 4.4%). Autosomal recessive disorders represented the predominant inheritance pattern (68.9%).

Conclusions

Our findings support ophthalmology-focused multigene panels as an effective first-line diagnostic strategy for patients with suspected genetic eye diseases. Early molecular testing may shorten the diagnostic odyssey, optimize resource utilization, facilitate precision diagnosis and genetic counseling, and guide future targeted deep phenotypic evaluation, prognosis, and eligibility for emerging gene-specific therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingEye Diseases, HereditaryEye DiseasesHumansFemaleMaleRetrospective StudiesAdultMiddle AgedChildHigh-Throughput Nucleotide SequencingAdolescentMutationChild, PreschoolYoung AdultAgedMyosin VIIa

Stichwörter der Autor:innen

genetic eye diseasesmolecular diagnosismultigene panelnext-generation sequencingophthalmic geneticsprecision medicine

Substanzen

Myosin VIIa

Autor:innen und Institutionen

  • Department of Genetics, University Hospital and Faculty of Medicine, Autonomous University of Nuevo León (UANL), Monterrey 64460, Mexico.
  • Department of Ophthalmology, University Hospital and Faculty of Medicine, Autonomous University of Nuevo León (UANL), Monterrey 64460, Mexico.

ORCID-Profile: Marisol Ibarra-Ramírez, Jibran Mohamed-Noriega, Joel Arenas-Estala, Marissa L Fernández-de-Luna

Zitieren

APA

Ibarra-Ramírez, M., Mohamed-Noriega, J., Arenas-Estala, J., Rodríguez-Torres, D. A., Campos-Acevedo, L. D., & Fernández-de-Luna, M. L. (2026). Early Molecular Testing for Presumptive Genetic Eye Diseases. Genes. https://doi.org/10.3390/genes17091092

Vancouver

Ibarra-Ramírez M, Mohamed-Noriega J, Arenas-Estala J, Rodríguez-Torres DA, Campos-Acevedo LD, Fernández-de-Luna ML. Early Molecular Testing for Presumptive Genetic Eye Diseases. Genes. 2026. doi:10.3390/genes17091092

BibTeX
@article{IbarraRamrez2026,
  author = {Ibarra-Ramírez, Marisol and Mohamed-Noriega, Jibran and Arenas-Estala, Joel and Rodríguez-Torres, David Asael and Campos-Acevedo, Luis Daniel and Fernández-de-Luna, Marissa L},
  title = {Early Molecular Testing for Presumptive Genetic Eye Diseases},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17091092}
}
Kostenlos starten →